Concepedia

Philip C. Hogan

PC

13

Publications

449

Citations

11

H-Index

2002

Active since

Affiliations

Harvard University(Current)

Tetraphase Pharmaceuticals (United States)

Harvard University Press

Philip C. Hogan is an author at Harvard University specializing in natural sciences, pharmacology, and organic chemistry.

Top concepts

PharmacologyNatural SciencesOrganic ChemistryMedicinal ChemistryChemistryBiochemistryEngineeringMedicineDrug DiscoveryBioorganic Chemistry

Publications per year

2002–2017

13

Publications

13

Proteasome Inhibition by a Totally Synthetic β-Lactam Related to Salinosporamide A and Omuralide

Philip C. Hogan, E. J. Corey · Journal of the American Chemical Society · 2005 · 73 citations

Molecular Pharmacology, Medicinal Chemistry, Proteasome Inhibition +15

Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy

Roger B. Clark, Diana K. Hunt, Minsheng He et al. · Journal of Medicinal Chemistry · 2011 · 71 citations

Medicinal Chemistry, Allergy, Antibiotics +14

Kedarcidin Chromophore: Synthesis of Its Proposed Structure and Evidence for a Stereochemical Revision

Feng Ren, Philip C. Hogan, Alan J. Anderson et al. · Journal of the American Chemical Society · 2007 · 70 citations

Combinatorial Chemistry, Biosynthesis, Bioorganic Chemistry +14

Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development

Magnus Rönn, Zhijian Zhu, Philip C. Hogan et al. · Organic Process Research & Development · 2013 · 59 citations

Pharmaceutical Science, Organic Chemistry, Pharmacotherapy +19

Enantioselective Synthesis of Kedarcidin Chromophore Aglycon in Differentially Protected Form

Andrew G. Myers, Philip C. Hogan, Alexander R. Hurd et al. · Angewandte Chemie International Edition · 2002 · 50 citations

Combinatorial Chemistry, Medicinal Chemistry, Transannular Anionic Cyclization +14

Rows per page

1–5 of 13